Clinical trial
Evaluation of [18F] FEPPA and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT00970333 is registered in ClinicalTrials.gov with Institute for Neurodegenerative Disorders as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of [18F] FEPPA and PET as a Marker of Inflammation in Subjects With Neurological Conditions
- Lead sponsor
- Institute for Neurodegenerative Disorders
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- October 31, 2010
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.